Stock Taper
SCREENER COMPARE ANY 2 STOCKS
PYPD
POLYPID LTD.
NASDAQ
$5.10
▲ UP 0.39% (0.02)

KEY STATISTICS

Market Cap$97.32 M
52w High$5.73
52w Low$3.06
Dividend Yield—
Frequency—
P/E-3.45
Volume169.11K
Shares Out.19.08M

COMPANY

LEADERSHIP

Dikla Czaczkes Akselbrad
CHIEF EXECUTIVE
Dikla Czaczkes Akselbrad

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 26, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
72

PRICE TARGET

Target High$13.00
Target Low$12.00
Target Median$12.50
Target Consensus$12.50

UPCOMING EARNINGS

DateNov 11, 2026
DayWednesday
Rev. Est.$800.00K
NOV
11
WED

SPLIT RECORD

DATETYPERATIO
2023-09-21Reverse1:30

PRICE

$5.10 ▲ UP 0.39% (+$0.02)
OVERLAYS
$5.02$5.10$5.179:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM5.10

About PolyPid Ltd.

https://www.polypid.com ↗

PolyPid Ltd., an Israeli late-stage biopharma company, develops PLEX platform-based products like D-PLEX100, currently in Phase III trials to prevent surgical site infections.

INDUSTRY

Biotechnology

A PRODUCT POLYPID LTD. IS KNOWN FOR

D-PLEX100
D-PLEX100

D-PLEX100 by PolyPid is a drug-eluting paste delivering doxycycline over 30 days to prevent surgical site infections, currently in late-stage regulatory review and nearing commercialization.

COMPETITORS

COMPETITOR
IART COMPARE
MDWD COMPARE
ORGO COMPARE
RCEL COMPARE
SMTI COMPARE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
16.15%
HOLDERS
19
TOP 12 OF 19 · RANKED BY POSITION SIZE
Aigh Capital Management LLC
1.6M sh · $6.98M
Rosalind Advisors, Inc.
597.9K sh · $2.62M
Dafna Capital Management LLC
207.9K sh · $910.6K
Morgan Stanley
176.9K sh · $774.79K
J. Goldman & Co LP
149.5K sh · $654.81K
Adar1 Capital Management, LLC
104.0K sh · $455.3K
Symmetry Peak Management LLC
87.2K sh · $381.9K
Citadel Advisors LLC
57.8K sh · $253.03K
Lumbard & Kellner, LLC
38.2K sh · $167.32K
Xtx Topco Ltd
29.5K sh · $129.05K
Jane Street Group, LLC
21.6K sh · $94.79K
Renaissance Technologies LLC
18.6K sh · $81.45K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
OFFICER: DEPUTY CEO, EVP, RD, CRA
Hazan Dalit Fellous
Purchase · 75.0K shares
2026-05-11
★
DIRECTOR
Barenholz Yechezkel
Purchase · 9.1K shares
2026-07-15
★
DIRECTOR
Stein Robert Benjamin
Purchase · 9.1K shares
2026-07-15
★
OFFICER: CHIEF FINANCIAL OFFICER
Missulawin Jonathan
Purchase · 49.0K shares
2026-05-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY Roth Capital BUY

SECTORS PEERS

PEERPRICE
ANVS$1.82COMPARE
VERU$2.64COMPARE
BTAI$0.80COMPARE
CELU$0.80COMPARE
EVAX$3.31COMPARE
PDSB$0.22COMPARE
RVPH$0.48COMPARE
BCAB$3.18COMPARE